相似文献
1
Caveolins in cardioprotection - translatability and mechanisms.
Br J Pharmacol. 2015 Apr;172(8):2114-25. doi: 10.1111/bph.13009. Epub 2015 Jan 13.
2
Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Pharmacol Rev. 2007 Dec;59(4):418-58. doi: 10.1124/pr.107.06002. Epub 2007 Nov 29.
3
Pathophysiology and molecular mechanism of caveolin involved in myocardial protection strategies in ischemic conditioning.
Biomed Pharmacother. 2022 Sep;153:113282. doi: 10.1016/j.biopha.2022.113282. Epub 2022 Jun 21.
4
Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus.
J Mol Cell Cardiol. 2016 Feb;91:11-22. doi: 10.1016/j.yjmcc.2015.12.020. Epub 2015 Dec 21.
5
Protection in the aged heart: preventing the heart-break of old age?
Cardiovasc Res. 2005 May 1;66(2):233-44. doi: 10.1016/j.cardiores.2004.12.020.
6
Inhalational anaesthetics and cardioprotection.
Handb Exp Pharmacol. 2008(182):187-207. doi: 10.1007/978-3-540-74806-9_9.
7
Remote ischaemic preconditioning: underlying mechanisms and clinical application.
Cardiovasc Res. 2008 Aug 1;79(3):377-86. doi: 10.1093/cvr/cvn114. Epub 2008 May 2.
8
Cardiac preconditioning for ischaemia: lost in translation.
Dis Model Mech. 2010 Jan-Feb;3(1-2):35-8. doi: 10.1242/dmm.003855.
9
Loss of cardioprotection with ageing.
Cardiovasc Res. 2009 Jul 15;83(2):247-61. doi: 10.1093/cvr/cvp033. Epub 2009 Jan 28.
10
The effect of body temperature on myocardial protection conferred by ischaemic preconditioning or the selective adenosine A1 receptor agonist GR79236, in an anaesthetized rabbit model of myocardial ischaemia and reperfusion.
Br J Pharmacol. 1999 Sep;128(2):385-95. doi: 10.1038/sj.bjp.0702799.
引用本文的文献
1
Caveolin-3: therapeutic target for diabetic myocardial ischemia/reperfusion injury.
Mol Med. 2025 Feb 26;31(1):80. doi: 10.1186/s10020-025-01117-5.
2
GLP-1 receptor agonist-based therapies and cardiovascular risk: a review of mechanisms.
J Endocrinol. 2024 Sep 19;263(1). doi: 10.1530/JOE-24-0046. Print 2024 Oct 1.
3
The purified extract of steamed protects cardiomyocyte from ischemic injury caveolin-1 phosphorylation-mediating calcium influx.
J Ginseng Res. 2023 Nov;47(6):755-765. doi: 10.1016/j.jgr.2023.07.003. Epub 2023 Aug 5.
4
Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action.
Nat Rev Cardiol. 2023 Jul;20(7):463-474. doi: 10.1038/s41569-023-00849-3. Epub 2023 Mar 28.
5
New Therapeutic Options for Type 2 Diabetes Mellitus and Their Impact Against Ischemic Heart Disease.
Front Physiol. 2022 Jun 27;13:904626. doi: 10.3389/fphys.2022.904626. eCollection 2022.
6
Pharmacological Conditioning of the Heart: An Update on Experimental Developments and Clinical Implications.
Int J Mol Sci. 2021 Mar 3;22(5):2519. doi: 10.3390/ijms22052519.
7
Morphine induces physiological, structural, and molecular benefits in the diabetic myocardium.
FASEB J. 2021 Mar;35(3):e21407. doi: 10.1096/fj.201903233R.
8
Dietary α-Linolenic Acid Counters Cardioprotective Dysfunction in Diabetic Mice: Unconventional PUFA Protection.
Nutrients. 2020 Sep 2;12(9):2679. doi: 10.3390/nu12092679.
9
Intralipid Increases Nitric Oxide Release from Human Endothelial Cells During Oxidative Stress.
JPEN J Parenter Enteral Nutr. 2021 Feb;45(2):295-302. doi: 10.1002/jpen.1834. Epub 2020 Apr 15.
10
Protective role of cardiac-specific overexpression of caveolin-3 in cirrhotic cardiomyopathy.
Am J Physiol Gastrointest Liver Physiol. 2020 Mar 1;318(3):G531-G541. doi: 10.1152/ajpgi.00346.2019. Epub 2020 Jan 21.
本文引用的文献
1
Caveolin-1 modulates cardiac gap junction homeostasis and arrhythmogenecity by regulating cSrc tyrosine kinase.
Circ Arrhythm Electrophysiol. 2014 Aug;7(4):701-10. doi: 10.1161/CIRCEP.113.001394. Epub 2014 Jul 13.
2
Role of aquaglyceroporins and caveolins in energy and metabolic homeostasis.
Mol Cell Endocrinol. 2014 Nov;397(1-2):78-92. doi: 10.1016/j.mce.2014.06.017. Epub 2014 Jul 4.
3
Regulation of intracellular signaling and function by caveolin.
FASEB J. 2014 Sep;28(9):3823-31. doi: 10.1096/fj.14-252320. Epub 2014 May 22.
4
Cardioprotective trafficking of caveolin to mitochondria is Gi-protein dependent.
Anesthesiology. 2014 Sep;121(3):538-48. doi: 10.1097/ALN.0000000000000295.
5
Long-term atorvastatin treatment leads to alterations in behavior, cognition, and hippocampal biochemistry.
Behav Brain Res. 2014 Jul 1;267:6-11. doi: 10.1016/j.bbr.2014.03.014. Epub 2014 Mar 19.
6
Statin treatment and new-onset diabetes: a review of proposed mechanisms.
Metabolism. 2014 Jun;63(6):735-45. doi: 10.1016/j.metabol.2014.02.014. Epub 2014 Feb 25.
7
An association of metabolic syndrome constellation with cellular membrane caveolae.
Pathobiol Aging Age Relat Dis. 2014 Feb 12;4. doi: 10.3402/pba.v4.23866. eCollection 2014.
8
The Concise Guide to PHARMACOLOGY 2013/14: enzymes.
Br J Pharmacol. 2013 Dec;170(8):1797-867. doi: 10.1111/bph.12451.
9
The Concise Guide to PHARMACOLOGY 2013/14: transporters.
Br J Pharmacol. 2013 Dec;170(8):1706-96. doi: 10.1111/bph.12450.
10
The Concise Guide to PHARMACOLOGY 2013/14: catalytic receptors.
Br J Pharmacol. 2013 Dec;170(8):1676-705. doi: 10.1111/bph.12449.
Zotero 插件